mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.0098 |
0.8 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |